Is it appropriate to treat unresectable secretory insulinoma of tail of the pancreas with radiation therapy?
What dose would you recommend? Any role for systemtic therapy?
Answer from: Radiation Oncologist at Academic Institution
Absolutely, it is the preferred treatment. Well differentiated functional NETs of the pancreas have been considered a resistant histology. However, the available data are based on palliative doses (BED<50Gy). It is an open question, but very likely that ablative doses (BED>100Gy) can overcome ...